Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-22

FDA Approved: MELPHALAN — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved Fresenius Kabi USA, LLC's original application for melphalan hydrochloride (melphalan hydrochloride) as a generic chemotherapy product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MELPHALAN HYDROCHLORIDE (MELPHALAN HYDROCHLORIDE)

Snippet

ORIG AP for MELPHALAN (MELPHALAN HYDROCHLORIDE)